Latest Strategic Shift News

Page 51 of 113
Atomos Ltd reported a 9% revenue decline in FY25, impacted by US tariffs and weak sales of new products, but has aggressively cut costs and revamped its strategy to fuel growth in FY26.
Sophie Babbage
Sophie Babbage
1 Sept 2025
Pro Medicus’s U.S. subsidiary Visage Imaging has earned a critical Authority to Operate from the U.S. Department of Veterans’ Affairs, enabling its Visage 7 CloudPACS platform to transition to the Veterans Affairs Enterprise Cloud.
Ada Torres
Ada Torres
1 Sept 2025
RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.
Ada Torres
Ada Torres
29 Aug 2025
Stakk Limited reports a striking 158% year-over-year revenue increase in FY25, driven by its Embedded Finance solutions and strategic partnerships. The company’s pivot from B2C to B2B signals a focused growth trajectory into FY26.
Claire Turing
Claire Turing
29 Aug 2025
TasFoods reports a $3.6 million net loss for H1 2025, impacted by oversupply and discounted poultry prices, while advancing key initiatives including pet treats expansion and planned divestments.
Eva Park
Eva Park
29 Aug 2025
Delorean Corporation reveals a strategic shift from EPC contractor to owner-operator of bioenergy assets, unveiling a $500 million-plus project portfolio despite a FY25 revenue dip and loss. The company is positioning itself at the forefront of Australia’s renewable gas market.
Victor Sage
Victor Sage
29 Aug 2025
Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.
Victor Sage
Victor Sage
29 Aug 2025
BauMart Holdings Limited has dramatically reduced its net loss to just $123,086 in FY25, down from $4.68 million the previous year, amid a strategic pivot and successful capital raise.
Victor Sage
Victor Sage
29 Aug 2025
BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.
Victor Sage
Victor Sage
29 Aug 2025
Yojee Limited reported a 34% revenue decline to $675k and a 29% reduction in net loss to $6.02 million for FY2025, reflecting a strategic pivot and accelerated development of its MOSAIC freight forwarding platform. The company raised $8.9 million to fund growth and platform commercialization.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.
Ada Torres
Ada Torres
29 Aug 2025